Answers are grounded in this paper and cite their sources.
The current review provided evidences that ADA might be a promising choice in reducing inflammatory activity, gaining VA, and sparing corticosteroid use with minor AEs when applied in treating non-infectious uveitis.
No takes yet. Share an insight, caveat, or question.
Ming et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: